TW200612966A - Boron-containing compounds and methods of use - Google Patents

Boron-containing compounds and methods of use

Info

Publication number
TW200612966A
TW200612966A TW094119690A TW94119690A TW200612966A TW 200612966 A TW200612966 A TW 200612966A TW 094119690 A TW094119690 A TW 094119690A TW 94119690 A TW94119690 A TW 94119690A TW 200612966 A TW200612966 A TW 200612966A
Authority
TW
Taiwan
Prior art keywords
methods
boron
containing compounds
antibiotics
acne
Prior art date
Application number
TW094119690A
Other languages
English (en)
Chinese (zh)
Inventor
David Perry
Kirk R Maples
Carolyn Bellinger-Kawahara
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of TW200612966A publication Critical patent/TW200612966A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW094119690A 2004-06-14 2005-06-14 Boron-containing compounds and methods of use TW200612966A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57942104P 2004-06-14 2004-06-14

Publications (1)

Publication Number Publication Date
TW200612966A true TW200612966A (en) 2006-05-01

Family

ID=35276660

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094119690A TW200612966A (en) 2004-06-14 2005-06-14 Boron-containing compounds and methods of use

Country Status (18)

Country Link
US (1) US7652000B2 (enExample)
EP (1) EP1765358B1 (enExample)
JP (1) JP2008502696A (enExample)
KR (1) KR20070043776A (enExample)
CN (1) CN1972695A (enExample)
AR (1) AR049915A1 (enExample)
AT (1) ATE499105T1 (enExample)
AU (1) AU2005254095B2 (enExample)
BR (1) BRPI0512054A (enExample)
CA (1) CA2570477A1 (enExample)
DE (1) DE602005026524D1 (enExample)
IL (1) IL179616A0 (enExample)
MX (1) MXPA06014416A (enExample)
NZ (1) NZ551726A (enExample)
RU (1) RU2007101309A (enExample)
TW (1) TW200612966A (enExample)
WO (1) WO2005123094A2 (enExample)
ZA (1) ZA200610353B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2414906C2 (ru) 2005-02-16 2011-03-27 Анакор Фармасьютикалз, Инк. Борсодержащие малые молекулы
RU2007139316A (ru) * 2005-03-24 2009-04-27 Анакор Фармасьютикалз, Инк. (Us) Местные композиции антибиотиков бориновой кислоты и способы их использования
CA2635840A1 (en) * 2005-12-28 2007-07-12 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
CN106008571A (zh) 2005-12-30 2016-10-12 安纳考尔医药公司 含硼的小分子
DK1988779T5 (en) 2006-02-16 2016-10-10 Anacor Pharmaceuticals Inc SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS
RU2008152367A (ru) * 2006-06-12 2010-07-20 Анакор Фармасьютикалз, Инк. (Us) Соединения для лечения периодонтального заболевания
CN102014927A (zh) 2008-03-06 2011-04-13 安纳考尔医药公司 作为抗炎药的含硼的小分子
US8853424B2 (en) * 2008-08-11 2014-10-07 Japan Science And Technology Agency Protein cross-linking inhibitor
EP2348863A4 (en) 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc BORN SMALL MOLECULES
WO2010028005A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US9493489B2 (en) * 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
TW201109022A (en) 2009-06-03 2011-03-16 Colgate Palmolive Co Borinic compositions
WO2011019618A1 (en) * 2009-08-14 2011-02-17 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011049971A1 (en) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011060199A1 (en) 2009-11-11 2011-05-19 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
CN108610356B (zh) 2010-09-07 2021-02-26 阿纳科制药公司 苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
CA2899317C (en) 2013-01-30 2024-09-10 Agrofresh Inc. USE OF BENZOXABOROLES AS VOLATILE ANTIMICROBIAL AGENTS ON MEAT, PLANTS, OR PARTS OF PLANTS
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
AU2016282382A1 (en) * 2015-06-24 2018-02-15 Oriel Seasalt Company Limited A highly concentrated seawater mineral extract and uses thereof
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
MA52337A (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals Inc Nouveaux analogues d'oxaborole et utilisations de ces derniers
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
US5348947A (en) * 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US6123925A (en) * 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
EP1233772A4 (en) * 1999-11-19 2004-06-16 Topgene Inc Boron compounds and complexes as anti-inflammatories
CN101928295A (zh) * 2002-12-18 2010-12-29 安那卡药品公司 含有烃基硼酸络合物的抗生素和使用方法

Also Published As

Publication number Publication date
ZA200610353B (en) 2010-07-28
RU2007101309A (ru) 2008-07-20
AU2005254095B2 (en) 2010-06-03
CN1972695A (zh) 2007-05-30
AR049915A1 (es) 2006-09-13
WO2005123094A2 (en) 2005-12-29
EP1765358B1 (en) 2011-02-23
BRPI0512054A (pt) 2008-02-06
DE602005026524D1 (de) 2011-04-07
MXPA06014416A (es) 2007-03-08
JP2008502696A (ja) 2008-01-31
EP1765358A2 (en) 2007-03-28
AU2005254095A1 (en) 2005-12-29
CA2570477A1 (en) 2005-12-29
KR20070043776A (ko) 2007-04-25
US7652000B2 (en) 2010-01-26
WO2005123094A3 (en) 2006-02-23
IL179616A0 (en) 2007-05-15
ATE499105T1 (de) 2011-03-15
US20060009422A1 (en) 2006-01-12
NZ551726A (en) 2010-09-30

Similar Documents

Publication Publication Date Title
TW200612966A (en) Boron-containing compounds and methods of use
TW200612939A (en) Antibiotics containing borinic acid complexes and methods of use
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
MXPA05009694A (es) Metodos para mejorar la calidad de la piel.
SG160412A1 (en) Anti-igfr1 antibody therapeutic combinations
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
WO2009156735A3 (en) New therapeutic agents
NO20054988D0 (no) Preparater og metoder for behandling av cancer
SG164368A1 (en) Treatment of cancer
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
WO2007096601A3 (en) Antimicrobial formulations comprising a quinone and a copper salt
IL164509A0 (en) Furyl compounds
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
WO2004030627A3 (en) Synergistic methods and compositions for treating cancer
EP2003976A4 (en) ANTIBACTERIAL COMPOSITION WITH ORGANIC SILVER COMPLEXES, ANTIBACTERIAL TREATMENT METHODS USING THEM, AND ANTIBACTERIAL FORM PIECE
MXPA05011785A (es) Moduladores positivos de receptores de acetilcolina nicotinicos.
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
PL1919466T3 (pl) Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu
PT1765360E (pt) Utilizações antivirais de complexos de ácido borínico
WO2006125555A3 (de) Chinazolinone
MX2008000838A (es) Composiciones y metodos para tratar infeccion bacteriana gram positiva en un sujeto mamifero.
WO2005094554A3 (en) Therapeutic agents, methods, and treatments
IL171875A0 (en) Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
WO2006033713A3 (en) Methods for ciprofloxacin inhalation